Servier

193 articles about Servier

• Galapagos NV Receives EUR4 Million in Milestones From Servier in Their Osteoarthritis Alliance

  12/15/2011

• MacroGenics, Inc. Inks Pharma Deal With Servier Worth Up to $450 Million

  12/1/2011

• Servier Enters Into a Type 2 Diabetes Partnership with Canadian Firm Prognomix Inc.

  11/8/2011

• miRagen Therapeutics Scores $352 Million Cardio microRNA Development Deal With Servier

  10/18/2011

• Hybrigenics and Servier Enter into a License and Research Collaboration Agreement in Oncology and Other Therapeutic Fields

  10/10/2011

• Servier Signs Cancer Pact with Galapagos NV for Up to €260 Million

  10/3/2011

• Servier Founder Ensnared in Mediator Scandal; Charged in Deaths and Granted 4 Million Euro Bail

  9/22/2011

• Servier Faces Another Scandal Over Another Drug

  9/9/2011

• Intercept Pharmaceuticals, Servier Announce up to $163 Million Agreement for Intercept's TGR5 Research Program in Type 2 Diabetes

  8/9/2011

• Cortex Pharmaceuticals, Inc. Enters into New Agreement with Servier; Cortex Could Possibly Receive $3 Million

  6/13/2011

• Servier Denies French Allegation of Concealing Mediator Diabetes Drug Risk

  5/9/2011

• Pharmacyclics, Inc. Achieves $7 Million Development Milestone for HDAC Inhibitor, PCI-24781/S 78454 with Servier

  4/26/2011

• Galapagos NV Receives EUR4 Million in Milestones from Servier

  2/8/2011

• Galapagos NV Receives EUR4 Million in Milestones from Servier

  2/8/2011

• XOMA (US) LLC and Servier Sign Pact for Top Diabetes Drug Candidate; XOMA Could Receive up to $505M

  1/4/2011

• Servier's Diabetes Drug, Mediator May Be Linked to 500 Deaths

  11/16/2010

• Vernalis PLC and Servier Achieve Research Milestone in 2nd Oncology Collaboration

  10/6/2010

• Osteologix Inc. and Servier Announce Ex-US Licensing Agreement

  8/2/2010

• Servier And Galapagos NV Initiate Strategic Alliance In Osteoarthritis

  7/1/2010

• Servier Collaborates with Shanghai Institute of Materia Medica on Cancer Drug Discovery

  10/15/2009